Maynard Um
-
-
-
-
-
-
-
Mineralys Therapeutics, Inc. (MLYS) Tops Q2 EPS by 40c
-
-
-
-
-
-
-
Mineralys Therapeutics, Inc. (MLYS) Tops Q1 EPS by 29c
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Mineralys Therapeutics, Inc. (MLYS)
-
-
-
-
-
-
-
Mineralys Therapeutics, Inc. (MLYS) Misses Q3 EPS by 42c
-
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

